Efficacy and safety of nirsevimab for preventing respiratory syncytial virus infection in infants: an updated systematic review and meta-analysis encompassing 11,001 participants
Baylor University Medical Center Proceedings | April 16, 2025 | Volume: 38 | Issue: 4 | Pages: 524-534
10.1080/08998280.2025.2488211